Circulatory benefits of diastolic counterpulsation in an ischemic heart failure model after aortomyoplasty

Nasim Hedayati, J. Timothy Sherwood, Steve J. Schomisch, Joseph L. Carino, Brian L. Cmolik

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: Aortomyoplasty is an experimental surgical procedure in which the latissimus dorsi muscle is wrapped around the thoracic aorta and stimulated to contract during diastole, providing diastolic counterpulsation. We hypothesized that aortomyoplasty could improve cardiac function in a chronic ischemic heart failure model, similar to the improvement seen with the intra-aortic balloon pump. Methods: Six dogs (25-30 kg) successfully underwent aortomyoplasty followed by serial coronary microembolization. Ejection fraction decreased from 63.5% to 36.5%. Two weeks after the final microembolization, the muscle was conditioned for 4 months to achieve fatigue resistance. One year after aortomyoplasty, hemodynamic studies during 1 hour of aortomyoplasty and 1 hour of intra-aortic balloon counterpulsation determined mean diastolic aortic pressure, peak left ventricular pressure, and endocardial viability ratio for assisted and unassisted beats. Cardiac output, stroke volume, and parameters of cardiac function were also measured. Results: Endocardial viability ratio increased by 23.8% ± 7.9% (P = .001) with aortomyoplasty counterpulsation and by 22.7% ± 12.9% (P = .021) with the intra-aortic balloon pump. Both aortomyoplasty and the intra-aortic balloon pump significantly increased mean diastolic aortic pressure and reduced peak left ventricular pressure. Improvements in cardiac function with aortomyoplasty and the intra-aortic balloon pump were similar. Cardiac output increased from 2.61 ± 0.88 to 3.07 ± 1.06 L/min (P = .006), and index of afterload decreased from 5.4 ± 1.4 to 4.8 ± 1.4 mm Hg/mL (P = .02) during 1 hour of aortomyoplasty counterpulsation. Conclusion: One year after the procedure, aortomyoplasty counterpulsation provided diastolic augmentation and improved cardiac performance similar to the improvement provided by the intra-aortic balloon pump in a chronic ischemic heart failure model. Aortomyoplasty has the potential to benefit patients with ischemic heart disease refractory to current therapies.

Original languageEnglish (US)
Pages (from-to)1067-1073
Number of pages7
JournalJournal of Thoracic and Cardiovascular Surgery
Volume123
Issue number6
DOIs
StatePublished - Jun 1 2002
Externally publishedYes

Fingerprint

Counterpulsation
Heart Failure
Ventricular Pressure
Cardiac Output
Arterial Pressure
Blood Pressure
Muscles
Diastole
Superficial Back Muscles
Thoracic Aorta
Stroke Volume
Myocardial Ischemia
Fatigue
Hemodynamics
Dogs

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Circulatory benefits of diastolic counterpulsation in an ischemic heart failure model after aortomyoplasty. / Hedayati, Nasim; Sherwood, J. Timothy; Schomisch, Steve J.; Carino, Joseph L.; Cmolik, Brian L.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 123, No. 6, 01.06.2002, p. 1067-1073.

Research output: Contribution to journalArticle

Hedayati, Nasim ; Sherwood, J. Timothy ; Schomisch, Steve J. ; Carino, Joseph L. ; Cmolik, Brian L. / Circulatory benefits of diastolic counterpulsation in an ischemic heart failure model after aortomyoplasty. In: Journal of Thoracic and Cardiovascular Surgery. 2002 ; Vol. 123, No. 6. pp. 1067-1073.
@article{39154b6f67b34d21bc6b505345468276,
title = "Circulatory benefits of diastolic counterpulsation in an ischemic heart failure model after aortomyoplasty",
abstract = "Objective: Aortomyoplasty is an experimental surgical procedure in which the latissimus dorsi muscle is wrapped around the thoracic aorta and stimulated to contract during diastole, providing diastolic counterpulsation. We hypothesized that aortomyoplasty could improve cardiac function in a chronic ischemic heart failure model, similar to the improvement seen with the intra-aortic balloon pump. Methods: Six dogs (25-30 kg) successfully underwent aortomyoplasty followed by serial coronary microembolization. Ejection fraction decreased from 63.5{\%} to 36.5{\%}. Two weeks after the final microembolization, the muscle was conditioned for 4 months to achieve fatigue resistance. One year after aortomyoplasty, hemodynamic studies during 1 hour of aortomyoplasty and 1 hour of intra-aortic balloon counterpulsation determined mean diastolic aortic pressure, peak left ventricular pressure, and endocardial viability ratio for assisted and unassisted beats. Cardiac output, stroke volume, and parameters of cardiac function were also measured. Results: Endocardial viability ratio increased by 23.8{\%} ± 7.9{\%} (P = .001) with aortomyoplasty counterpulsation and by 22.7{\%} ± 12.9{\%} (P = .021) with the intra-aortic balloon pump. Both aortomyoplasty and the intra-aortic balloon pump significantly increased mean diastolic aortic pressure and reduced peak left ventricular pressure. Improvements in cardiac function with aortomyoplasty and the intra-aortic balloon pump were similar. Cardiac output increased from 2.61 ± 0.88 to 3.07 ± 1.06 L/min (P = .006), and index of afterload decreased from 5.4 ± 1.4 to 4.8 ± 1.4 mm Hg/mL (P = .02) during 1 hour of aortomyoplasty counterpulsation. Conclusion: One year after the procedure, aortomyoplasty counterpulsation provided diastolic augmentation and improved cardiac performance similar to the improvement provided by the intra-aortic balloon pump in a chronic ischemic heart failure model. Aortomyoplasty has the potential to benefit patients with ischemic heart disease refractory to current therapies.",
author = "Nasim Hedayati and Sherwood, {J. Timothy} and Schomisch, {Steve J.} and Carino, {Joseph L.} and Cmolik, {Brian L.}",
year = "2002",
month = "6",
day = "1",
doi = "10.1067/mtc.2002.121682",
language = "English (US)",
volume = "123",
pages = "1067--1073",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Circulatory benefits of diastolic counterpulsation in an ischemic heart failure model after aortomyoplasty

AU - Hedayati, Nasim

AU - Sherwood, J. Timothy

AU - Schomisch, Steve J.

AU - Carino, Joseph L.

AU - Cmolik, Brian L.

PY - 2002/6/1

Y1 - 2002/6/1

N2 - Objective: Aortomyoplasty is an experimental surgical procedure in which the latissimus dorsi muscle is wrapped around the thoracic aorta and stimulated to contract during diastole, providing diastolic counterpulsation. We hypothesized that aortomyoplasty could improve cardiac function in a chronic ischemic heart failure model, similar to the improvement seen with the intra-aortic balloon pump. Methods: Six dogs (25-30 kg) successfully underwent aortomyoplasty followed by serial coronary microembolization. Ejection fraction decreased from 63.5% to 36.5%. Two weeks after the final microembolization, the muscle was conditioned for 4 months to achieve fatigue resistance. One year after aortomyoplasty, hemodynamic studies during 1 hour of aortomyoplasty and 1 hour of intra-aortic balloon counterpulsation determined mean diastolic aortic pressure, peak left ventricular pressure, and endocardial viability ratio for assisted and unassisted beats. Cardiac output, stroke volume, and parameters of cardiac function were also measured. Results: Endocardial viability ratio increased by 23.8% ± 7.9% (P = .001) with aortomyoplasty counterpulsation and by 22.7% ± 12.9% (P = .021) with the intra-aortic balloon pump. Both aortomyoplasty and the intra-aortic balloon pump significantly increased mean diastolic aortic pressure and reduced peak left ventricular pressure. Improvements in cardiac function with aortomyoplasty and the intra-aortic balloon pump were similar. Cardiac output increased from 2.61 ± 0.88 to 3.07 ± 1.06 L/min (P = .006), and index of afterload decreased from 5.4 ± 1.4 to 4.8 ± 1.4 mm Hg/mL (P = .02) during 1 hour of aortomyoplasty counterpulsation. Conclusion: One year after the procedure, aortomyoplasty counterpulsation provided diastolic augmentation and improved cardiac performance similar to the improvement provided by the intra-aortic balloon pump in a chronic ischemic heart failure model. Aortomyoplasty has the potential to benefit patients with ischemic heart disease refractory to current therapies.

AB - Objective: Aortomyoplasty is an experimental surgical procedure in which the latissimus dorsi muscle is wrapped around the thoracic aorta and stimulated to contract during diastole, providing diastolic counterpulsation. We hypothesized that aortomyoplasty could improve cardiac function in a chronic ischemic heart failure model, similar to the improvement seen with the intra-aortic balloon pump. Methods: Six dogs (25-30 kg) successfully underwent aortomyoplasty followed by serial coronary microembolization. Ejection fraction decreased from 63.5% to 36.5%. Two weeks after the final microembolization, the muscle was conditioned for 4 months to achieve fatigue resistance. One year after aortomyoplasty, hemodynamic studies during 1 hour of aortomyoplasty and 1 hour of intra-aortic balloon counterpulsation determined mean diastolic aortic pressure, peak left ventricular pressure, and endocardial viability ratio for assisted and unassisted beats. Cardiac output, stroke volume, and parameters of cardiac function were also measured. Results: Endocardial viability ratio increased by 23.8% ± 7.9% (P = .001) with aortomyoplasty counterpulsation and by 22.7% ± 12.9% (P = .021) with the intra-aortic balloon pump. Both aortomyoplasty and the intra-aortic balloon pump significantly increased mean diastolic aortic pressure and reduced peak left ventricular pressure. Improvements in cardiac function with aortomyoplasty and the intra-aortic balloon pump were similar. Cardiac output increased from 2.61 ± 0.88 to 3.07 ± 1.06 L/min (P = .006), and index of afterload decreased from 5.4 ± 1.4 to 4.8 ± 1.4 mm Hg/mL (P = .02) during 1 hour of aortomyoplasty counterpulsation. Conclusion: One year after the procedure, aortomyoplasty counterpulsation provided diastolic augmentation and improved cardiac performance similar to the improvement provided by the intra-aortic balloon pump in a chronic ischemic heart failure model. Aortomyoplasty has the potential to benefit patients with ischemic heart disease refractory to current therapies.

UR - http://www.scopus.com/inward/record.url?scp=0036621646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036621646&partnerID=8YFLogxK

U2 - 10.1067/mtc.2002.121682

DO - 10.1067/mtc.2002.121682

M3 - Article

C2 - 12063452

AN - SCOPUS:0036621646

VL - 123

SP - 1067

EP - 1073

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 6

ER -